NCT01043094View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

December 31, 2010

Conditions
Severe Renal Impairment
Interventions
DRUG

Pitavastatin 4mg

Pitavastatin 4mg single dose

Trial Locations (1)

Unknown

Minneapolis

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY